Netflix Took 10 Years To Accomplish What One Company Could Do In Just 3

In clinical studies, it reduced the frequency of seizures for individuals with Dravet syndrome by 39%. Those with LGS saw between a 37% to 42% reduction (dependent on the dosage amount).

Thanks to the problem GW Pharma is helping to solve, Epidiolex sales reached $296 million. In 2020, sales are on track for $500 million.

By 2021, Epidolex sales could reach $1 billion.

Again, reaching that milestone would be faster than Apple (AAPL).

Or Netflix.

Or Google.

And things have worked out for those who have invested in those companies early.

But GW Pharma is only one of the many other cannabis companies that are growing this fast. And unlike GWPH, several of those other stocks can still be had for under $10 per share, with the potential to return up to 30X your money by next year.

1 2
View single page >> |

Disclosure: None.

How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.